Moreover, we investigated the correlation of properdin with tumor-infiltrating immune cells (TIICs) in all 4 types of cancers via Tumor IMmune Estimation Resource (TIMER) and performed immunohistochemical analysis to identify the most likely sources of properdin in the tumor microenvironment. The gene discussed is CFP; the disease is cancer.